Escitalopram in a Patient with Hyponatremia

Mechanism: How SSRIs Cause Hyponatremia

• Median time to onset of SSRI-induced hyponatremia: 13 days (range 3-120 days)
• Approximately 12% of elderly patients on an SSRI develop SIADH
• The vast majority of reported cases involve patients older than 65 years
• Hyponatremia most commonly develops shortly after starting the drug

Clinical Decision Framework

Key Risk Factors That Increase Risk

• Age > 65 years (by far the biggest risk factor)
• Female sex
• Low body weight
• Concurrent use of diuretics (especially thiazides)
• Baseline low-normal serum sodium
• Concomitant drugs that also cause SIADH (carbamazepine, antipsychotics)

What to Do If Escitalopram Is Clinically Necessary

1. Correct the hyponatremia first (fluid restriction, treat underlying cause) before starting escitalopram
2. Check baseline serum Na before starting
3. Recheck serum Na at 1-2 weeks after initiation, then at 4 weeks
4. Educate patient/family about symptoms: nausea, headache, confusion, seizures
5. Avoid concomitant thiazide diuretics if possible

Safer Alternatives in Patients Prone to Hyponatremia

• Mirtazapine - noradrenergic/specific serotonergic antidepressant; lower risk of SIADH because it blocks certain serotonin receptors rather than increasing serotonergic tone globally
• Bupropion - dopamine/norepinephrine reuptake inhibitor; no serotonergic mechanism, no known association with SIADH
• Nortriptyline (TCA) - some reports of SIADH but less common than SSRIs; less preferred due to other side effects in elderly

Note: Among SSRIs, citalopram and escitalopram are specifically highlighted as carrying this risk, alongside other class members. Escitalopram is safer than citalopram in overdose (less QT prolongation), but both share the SIADH risk at therapeutic doses. (Goldman-Cecil Medicine; Rosen's EM)

Summary

Escitalopram in a 32-Year-Old with High-Output Stoma and Hyponatremia

This Changes Everything

Pathophysiology of Hyponatremia in High-Output Stoma

1. Direct sodium loss - small bowel fluid contains ~90-100 mmol/L of Na+
2. Volume depletion - triggers secondary ADH release (this is appropriate/compensatory ADH, not SIADH)
3. The compensatory ADH causes water retention in an attempt to restore volume, but since Na+ losses exceed water replacement, the result is hypovolemic hyponatremia
4. Urine Na+ is typically <20 mmol/L (kidneys avidly retaining sodium - key distinguishing feature from SIADH)

Why the SSRI-SIADH Risk Is Much Less Relevant Here

• Young age (SIADH from SSRIs is overwhelmingly an elderly problem; ~12% of elderly vs. rare in young adults)
• The dominant mechanism of hyponatremia is entirely different and correctable

Clinical Conclusion

1. Treat the underlying cause first - the high-output stoma must be managed aggressively:
   • Fluid and electrolyte replacement (isotonic saline is the treatment of choice for hypovolemic hyponatremia)
   • Anti-motility agents (loperamide, codeine phosphate)
   • Anti-secretory agents (omeprazole, octreotide in refractory cases)
   • Oral rehydration with glucose-sodium solutions (St. Mark's solution)
   • Magnesium and other electrolyte supplementation
2. Correct or stabilize the sodium before starting escitalopram if it is severely low (Na <125 mEq/L)
3. Monitor sodium at 1-2 weeks after starting escitalopram
4. The additive SIADH risk from escitalopram is real but small in a young patient - it must not be the reason to withhold treatment for depression, which itself worsens quality of life and functional outcomes in stoma patients
5. If hyponatremia proves refractory or recurrent despite stoma management, consider mirtazapine or bupropion as alternatives with no SIADH risk

The key clinical insight: do not conflate the mechanism. This patient's hyponatremia needs sodium replacement, not fluid restriction. Treating the stoma output is the priority; escitalopram itself is unlikely to be the limiting factor here. (Ref: Wen et al., J Multidiscip Healthc 2026 - systematic review of fluid/electrolyte strategies in high-output stomas [PMID 41710394])

Na+ 116 mEq/L with High-Output Stoma - Full Clinical Answer

Step 1: Forget Escitalopram for Now

Immediate Management

First - Assess for Symptoms (this determines urgency)

This Patient: Hypovolemic Hyponatremia from GI Losses

• 3% hypertonic saline 100 mL IV over 10 minutes as a bolus
• Can repeat a second 100 mL bolus over the next 50 minutes if still symptomatic
• Target: raise Na by 4-6 mEq/L within the first 6 hours - sufficient to reverse severe manifestations
• If the sodium is rising too fast, stop saline and give D5W to slow the rise

• Normal saline (0.9%) - start at 500-1000 mL/hr until hemodynamically stable, then slow to 200 mL/hr
• Frequent sodium checks (every 2-4 hours)

The Most Important Rule - Correction Limits

⚠️ Do NOT exceed these rates - osmotic demyelination syndrome (ODS) is catastrophic and irreversible

• If ODS symptoms appear during correction: stop all sodium-containing fluids immediately, give D5W
• ODS risk is highest in malnourished patients, alcoholics, liver disease, hypokalemia - assess for these

Alongside Sodium Correction - Treat the Stoma

1. Anti-motility agents - loperamide 4 mg with meals and 2 mg after each loose output (up to 16 mg/day); codeine phosphate 30-60 mg QDS
2. Anti-secretory agents - proton pump inhibitor (omeprazole 40 mg BD reduces upper GI secretions)
3. Oral rehydration solution - St. Mark's solution (contains Na 90 mmol/L - optimally absorbed); plain water actually worsens stoma output
4. Replace magnesium - frequently co-depleted and often missed; check Mg2+
5. Replace potassium - check and replace aggressively; hypokalemia worsens hyponatremia correction
6. Octreotide in refractory high-output stoma (reduces secretory output)

Disposition

• Admit to ICU - Na 116 with a high-output stoma requires continuous monitoring
• Nephrology consult for symptomatic hyponatremia or rapidly changing sodium
• Stoma/colorectal surgery team review
• Dietetics and nutrition review
• Serial sodium levels every 2-4 hours while correcting

Back to Escitalopram

• Na is stable and trending toward ≥125-130 mEq/L
• The stoma output is controlled
• The patient is clinically well